Farzaneh Dastan

InstitutionShahid beheshti university of medical sciences
AddressTehran
Iran
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 25 Covid-19 publications, with a maximum of 4 publications in January 2020 and November 2020
    All Publications
    Bar chart showing 32 publications over 6 distinct years, with a maximum of 17 publications in 2020
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Barati S, MohammadReza Hashemian S, Tabarsi P, Abedini A, Ashrafzadeh M, Haseli S, Abtahian Z, Yousefian S, Dastan A, Sobhanian A, Dastan F. Combined Therapy of Ciclosporin Plus Favipiravir in the Management of Patients with Severe COVID-19, not Responding to Dexamethasone: A non-Controlled Prospective Trial. Int Immunopharmacol. 2021 Oct; 99:108043. PMID: 34426105.
      Citations:    Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    2. Tabarsi P, Hashemian SMR, Bauhofer A, Savadkoohi AA, Ghadimi S, Haseli S, Dastan F. IgM-enriched immunoglobulin in COVID-19: Case series of 15 severely ill SARS-CoV-2-infected patients. Int Immunopharmacol. 2021 Oct; 99:107998. PMID: 34315117.
      Citations:    Fields:    Translation:Humans
    3. Fakharian A, Barati S, Mirenayat M, Rezaei M, Haseli S, Torkaman P, Yousefian S, Dastan A, Jamaati H, Dastan F. Evaluation of adalimumab effects in managing severe cases of COVID-19: A randomized controlled trial. Int Immunopharmacol. 2021 Oct; 99:107961. PMID: 34426106.
      Citations: 1     Fields:    Translation:HumansCTClinical Trials
    4. Jamshidi E, Asgary A, Tavakoli N, Zali A, Dastan F, Daaee A, Badakhshan M, Esmaily H, Jamaldini SH, Safari S, Bastanhagh E, Maher A, Babajani A, Mehrazi M, Sendani Kashi MA, Jamshidi M, Sendani MH, Rahi SJ, Mansouri N. Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning. Front Artif Intell. 2021; 4:673527. PMID: 34250465.
      Citations: 1     
    5. Rezaei S, Fatemi B, Karimi Majd Z, Minaei H, Peikanpour M, Anjidani N, Taheri A, Dastan F, Mosaed R. Efficacy and safety of Tocilizumab in severe and critical COVID-19: A Systematic Review and Meta-Analysis. Expert Rev Clin Immunol. 2021 05; 17(5):499-511. PMID: 33823733.
      Citations: 4     Fields:    Translation:Humans
    6. Tolouian R, Mulla ZD, Jamaati H, Babamahmoodi A, Marjani M, Eskandari R, Dastan F. Effect of bromhexine in hospitalized patients with COVID-19. J Investig Med. 2021 Mar 15. PMID: 33722999.
      Citations: 1     Fields:    
    7. Jamaati H, Hashemian SM, Farzanegan B, Malekmohammad M, Tabarsi P, Marjani M, Moniri A, Abtahian Z, Haseli S, Mortaz E, Dastan A, Mohamadnia A, Vahedi A, Monjazebi F, Yassari F, Fadaeizadeh L, Saffaei A, Dastan F. No clinical benefit of high dose corticosteroid administration in patients with COVID-19: A preliminary report of a randomized clinical trial. Eur J Pharmacol. 2021 Apr 15; 897:173947. PMID: 33607104.
      Citations: 12     Fields:    Translation:Humans
    8. Fakharian A, Barati S, Mohamadi M, Dastan F. Successful Management of COVID-19 With Adalimumab in a Post-Coronary Artery Bypass Graft Surgery Patient. J Cardiothorac Vasc Anesth. 2021 Jan 07. PMID: 33423911.
      Citations: 2     Fields:    
    9. Baghaei P, Dastan F, Marjani M, Moniri A, Abtahian Z, Ghadimi S, Valizadeh M, Heshmatnia J, Sadat Mirenayat M, Abedini A, Kiani A, Eslaminejad A, MohammadReza Hashemian S, Jamaati H, Zali A, Akbar Velayati A, Tabarsi P. Combination therapy of IFNß1 with lopinavir-ritonavir, increases oxygenation, survival and discharging of sever COVID-19 infected inpatients. Int Immunopharmacol. 2021 Mar; 92:107329. PMID: 33412395.
      Citations: 9     Fields:    Translation:Humans
    10. Hashemian SM, Shafigh N, Afzal G, Jamaati H, Mortaz E, Tabarsi P, Marjani M, Malekmohammad M, Dastan F, Mortazavi SM, Sadr M, Idani E, Khoundabi B, Mohamadnia A, Abedini A, Kiani A, Moniri A, Nadji SA, Yassari F, Mokhber Dezfuli M, Pourabdollah M, Varahram M, Eshaghi F, Malekpour M, Velayati A. Blood Purification Techniques, Inflammatory Mediators and Mortality in COVID-19 Patients. Tanaffos. 2020 Dec; 19(4):291-299. PMID: 33959166.
      Citations: 1     
    11. Tabarsi P, Barati S, Jamaati H, Haseli S, Marjani M, Moniri A, Abtahian Z, Dastan A, Yousefian S, Eskandari R, Saffaei A, Monjazebi F, Vahedi A, Dastan F. Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial. Int Immunopharmacol. 2021 Jan; 90:107205. PMID: 33214093.
      Citations: 18     Fields:    Translation:Humans
    12. Citations: 2     
    13. Najafi A, Ghanei M, Janbabaei G, Velayati AA, Saadat SH, Jamaati H, Tabarsi P, Dastan F, Ram M, Darabi E, Fathi S, Gholami Fesharaki M, Ghazale AH, Saloo S. Real Clinical Practice and Therapeutic Management Following COVID-19 Crisis in two Hospitals in Iran: A Statistical and Conceptual View. Tanaffos. 2020 Nov; 19(2):112-121. PMID: 33262798.
      Citations:    
    14. Baghaei P, Nadji SA, Marjani M, Moniri A, Hashemian SM, Sheikhzade H, Abtahian Z, Heshmatnia J, Abedini A, Jamaati H, Mansourafshar B, Ahmadi ZH, Mokhber Dezfuli M, Seifi S, Sadeghi M, Mirenayat MS, Yassari F, Lookzadeh S, Farzanegan B, Kiani A, Vasheghani M, Dastan F, Eslaminejad A, Malekmohammad M, Varahram M, Zali A, Tabarsi P, Velayati AA. Clinical Manifestations of Patients with Coronavirus Disease 2019 (COVID-19) in a Referral Center in Iran. Tanaffos. 2020 Nov; 19(2):122-128. PMID: 33262799.
      Citations:    
    15. Malekzadeh R, Abedini A, Mohsenpour B, Sharifipour E, Ghasemian R, Javad-Mousavi SA, Khodashahi R, Darban M, Kalantari S, Abdollahi N, Salehi MR, Rezaei Hosseinabadi A, Khorvash F, Valizadeh M, Dastan F, Yousefian S, Hosseini H, Anjidani N, Tabarsi P. Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial. Int Immunopharmacol. 2020 Dec; 89(Pt B):107102. PMID: 33075713.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    16. Dastan F, Saffaei A, Haseli S, Marjani M, Moniri A, Abtahian Z, Abedini A, Kiani A, Seifi S, Jammati H, Hashemian SMR, Pourabdollah Toutkaboni M, Eslaminejad A, Heshmatnia J, Sadeghi M, Nadji SA, Dastan A, Baghaei P, Varahram M, Yousefian S, Salamzadeh J, Tabarsi P. Promising effects of tocilizumab in COVID-19: A non-controlled, prospective clinical trial. Int Immunopharmacol. 2020 Nov; 88:106869. PMID: 32889241.
      Citations: 18     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    17. Ahmadi ZH, Jahangirifard A, Farzanegan B, Tabarsi P, Abtahian Z, Abedini A, Sharifi M, Jadbabaei AN, Mafhumi Y, Moslem A, Sistani M, Yousefian S, Saffaei A, Dastan F. Extracorporeal membrane oxygenation and COVID-19: The causes of failure. J Card Surg. 2020 Oct; 35(10):2838-2843. PMID: 32678961.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    18. Dastan F, Nadji SA, Saffaei A, Marjani M, Moniri A, Jamaati H, Hashemian SM, Baghaei P, Abedini A, Varahram M, Yousefian S, Tabarsi P. Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial. Int Immunopharmacol. 2020 Aug; 85:106688. PMID: 32544867.
      Citations: 29     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    19. Dastan F, Nadji SA, Saffaei A, Tabarsi P. Tocilizumab administration in a refractory case of COVID-19. Int J Antimicrob Agents. 2020 Aug; 56(2):106043. PMID: 32502524.
      Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
    20. Dastan F, Abedini A, Shahabi S, Kiani A, Saffaei A, Zare A. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung. Iran J Allergy Asthma Immunol. 2020 May 17; 19(S1):10-12. PMID: 32534505.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    21. Dastan F, Saffaei A, Mortazavi SM, Jamaati H, Adnani N, Samiee Roudi S, Kiani A, Abedini A, Hashemian SM. Continues renal replacement therapy (CRRT) with disposable hemoperfusion cartridge: A promising option for severe COVID-19. J Glob Antimicrob Resist. 2020 06; 21:340-341. PMID: 32353526.
      Citations: 12     Fields:    Translation:HumansCellsPHPublic Health
    22. Dastan F, Tabarsi P, Marjani M, Moniri A, Hashemian SMR, Tavakoli-Ardakani M, Saffaei A. Thalidomide against Coronavirus Disease 2019 (COVID-19): A Medicine with a Thousand Faces. Iran J Pharm Res. 2020; 19(1):1-2. PMID: 32922463.
      Citations: 6     
    23. Jamaati H, Dastan F, Tabarsi P, Marjani M, Saffaei A, Hashemian SM. A Fourteen-day Experience with Coronavirus Disease 2019 (COVID-19) Induced Acute Respiratory Distress Syndrome (ARDS): An Iranian Treatment Protocol. Iran J Pharm Res. 2020; 19(1):31-36. PMID: 32922466.
      Citations: 15     
    24. Jamaati H, Dastan F, Esmaeili Dolabi S, Varahram M, Hashemian SM, Nasiri Rayeini S, Farzanegan B, Monjazebi F. COVID-19 in Iran: A model for Crisis Management and Current Experience. Iran J Pharm Res. 2020; 19(2):1-8. PMID: 33224206.
      Citations: 2     
    25. Mohammadi Barzelighi H, Daraei B, Dastan F. Approaches for the Treatment of SARS-CoV-2 Infection: A Pharmacologic View and Literature Review. Iran J Pharm Res. 2020; 19(3):258-281. PMID: 33680028.
      Citations: 1     
    Dastan's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (78)
    Explore
    _
    Co-Authors (142)
    Explore
    _
    Similar People (60)
    Explore
    _